Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?

Eunjin Hong; Paul M. Beringer

doi:10.1002/psp4.13134

Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?

Eunjin Hong
, Paul M. Beringer

Department of Pharmacy

University of Southern California

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	509-510
Number of pages	2
Journal	CPT: Pharmacometrics and Systems Pharmacology
Volume	13
Issue number	4
DOIs	https://doi.org/10.1002/psp4.13134
State	Published - Apr 2024

Access to Document

10.1002/psp4.13134

Cite this

@article{e19dbd2eee964d4985798c9c89eb4f62,

title = "Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?",

author = "Eunjin Hong and Beringer, \{Paul M.\}",

year = "2024",

month = apr,

doi = "10.1002/psp4.13134",

language = "English",

volume = "13",

pages = "509--510",

journal = "CPT: Pharmacometrics and Systems Pharmacology",

issn = "2163-8306",

publisher = "American Society for Clinical Pharmacology and Therapeutics",

number = "4",

}

TY - JOUR

T1 - Development of a cystic fibrosis population model for physiologically based pharmacokinetic models

T2 - Is it worth it?

AU - Hong, Eunjin

AU - Beringer, Paul M.

PY - 2024/4

Y1 - 2024/4

UR - https://www.scopus.com/pages/publications/85189102149

U2 - 10.1002/psp4.13134

DO - 10.1002/psp4.13134

M3 - Letter

C2 - 38511610

AN - SCOPUS:85189102149

SN - 2163-8306

VL - 13

SP - 509

EP - 510

JO - CPT: Pharmacometrics and Systems Pharmacology

JF - CPT: Pharmacometrics and Systems Pharmacology

IS - 4

ER -

Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?

Access to Document

Other files and links

Cite this